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Abstract: Background: Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neurodegenerative 
disease of the motor neurons. The etiology of ALS remains largely unknown, particularly with 
reference to the potential environmental determinants. Methods: We performed a population-based 
case-control study in four provinces from both Northern and Southern Italy in order to assess non-
genetic ALS risk factors by collecting through tailored questionnaires information about clinical and 
lifestyle factors. We estimated ALS risk by calculating odds ratio (OR) with its 95% confidence 
interval (CI) using unconditional logistic regression models adjusted for sex, age and educational 
attainment. Results: We recruited 230 participants (95 cases and 135 controls). We found a possible 
positive association of ALS risk with trauma, particularly head trauma (OR = 2.61, 95% CI 1.19–5.72), 
electric shock (OR = 2.09, 95% CI 0.62–7.06), and some sports, although at a competitive level only. 
In addition, our results suggest an increased risk for subjects reporting use of private wells for 
drinking water (OR = 1.38, 95% CI 0.73–2.27) and for use of herbicides during gardening (OR = 1.95, 
95% CI 0.88–2.27). Conversely, there was a suggestion of an inverse association with overall fish 
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consumption (OR = 0.27, 95% CI 0.12–0.60), but with no dose-response relation. Consumption of 
some dietary supplements, namely those containing amino acids and, in the Southern Italy 
population, vitamins and minerals such as selenium, seemed associated with a statistically 
imprecise increased risk. Conclusions: Our results suggest a potential etiologic role a number of 
clinical and lifestyle factors with ALS risk. However, caution is needed due to some study 
limitations. These include the small sample size and the low number of exposed subjects, which 
affect statistical precision of risk estimates, the potential for exposure misclassification, and the 
uncertainties about mechanisms underpinning the possible association between these factors and 
disease risk. 
Keywords: amyotrophic lateral sclerosis; case-control study; environmental factors; trauma; diet 
 
1. Introduction 
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects both upper and 
lower motor neurons. Disease progression is generally rapid and, after substantial respiratory and 
nutritional failure, leads to death in 70–80% of affected individuals within 5 years [1–3]. The 
worldwide prevalence of ALS is approximately 6 cases per 100,000 individuals [4], while annual 
incidence varies worldwide from approximately 1 to 2.6 cases per 100,000 individuals. In terms of 
geographical distribution, incidence is higher in populations of European than Asian origin [5]. An 
increase in ALS incidence has been reported in recent decades [6], in Italy as well [7–11]. Despite 
progress in assessing the role of genetic factors [12], the etiology of ALS remains largely unknown. 
To date, the only recognized risk factors are male sex, older age and a family history of ALS, which 
is frequently associated with specific gene mutations [13]. Many putative exogenous factors have 
been investigated, including exposure to pesticides, electromagnetic fields, some metals, 
cyanobacteria contamination, as well as a history of medical conditions and lifestyle choices [14–19]. 
Nevertheless, a definite environmental risk factor has not been identified so far. In the present study, 
we aimed at investigating the association between clinical history, lifestyles, and other personal 
characteristics with the risk of ALS using a large population-based case-control study in four Italian 
provinces. 
2. Methods 
Subsequent to approval by the Ethics Committees of Catania, Modena and Reggio Emilia (no. 
80/11), and Novara (no. 4/12), we designed a population-based case-control study to investigate the 
role of clinical and environmental factors in the etiology of ALS. We attempted to recruit all sporadic 
ALS cases diagnosed in the period 2008–2011 in the provinces of Catania, Modena, and Reggio Emilia, 
and in the period 2002–2012 in Novara province. 
We used multiple sources for the identification of eligible cases: the Emilia-Romagna Registry 
for ALS (ERRALS, established in 2009), and the Piedmont and Valle d’Aosta Register for ALS 
(PARALS, established in 1995), including hospital discharge records for the entire study period, death 
certificate files, and the drug prescription directories of Emilia-Romagna, Piedmont and Sicily. We 
only included in the study patients diagnosed with ‘definite’ and ‘probable’ ALS based on the El 
Escorial revised criteria. We therefore excluded familial cases [20]. Finally, we tested cases for repeat 
expansions in the C9orf72 gene. 
Using the National Health Service directory of the residents in the study provinces, we randomly 
selected controls from four populations, matched by sex, age (+/−5) and province of residence. We 
recruited cases either at the Neurology Units of the study area or by contacting them by phone and/or 
regular-mail. Study materials included an information leaflet with the description of study aim, 
methods and contact details of the study investigators, the informed consent form, the questionnaire, 
and a prepaid return envelope for those contacted by mail. 
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We estimated ALS risk by calculating the disease odds ratio (OR) and 95 % confidence intervals 
(CI) in crude and adjusted unconditional logistic regression models. We included sex, age, and 
educational attainment as potential confounders in the multivariable model. We also performed 
stratified analysis by sex and geographic area (Southern versus Northern Italy, i.e., the Catania 
province as opposed to remaining provinces). We used Stata Software (v16.1, Stata Corp, College 
Station, TX, USA, 2019) for all data analysis. 
3. Results 
Table 1 shows the characteristics of the 230 participants who accepted to participate in the study. 
The average response rate was 19.0% (230/1211), higher in Emilia-Romagna (122/462 = 24.6%), 
followed by Piedmont (68/337 = 20.2%) and Sicily (40/412 = 9.7%).  







All subjects 95 (100) 135 (100) 230 (100) 
Sex    
Men 51 (53.7) 71 (52.6) 122 (53.0) 
Women 44 (46.3) 64 (47.4) 108 (47.0) 
Age    
Mean (SD) years 64.9 (11.7) 66.5 (10.3) 65.8 (10.9) 
< 65 years 46 (48.4) 56 (41.5) 102 (44.3) 
≥ 65 years 49 (51.6) 79 (58.5) 128 (55.6) 
Province of residence    
Catania 19 (20.0) 21 (15.6) 40 (17.4) 
Modena 29 (30.5) 47 (34.8) 76 (33.0) 
Reggio Emilia 13 (13.7) 33 (24.4) 46 (20.0) 
Novara 34 (37.8) 34 (25.2) 68 (29.6) 
Educational attainment    
Primary school or less 40 (42.1) 47 (34.8) 87 (37.8) 
Middle school 24 (25.3) 28 (20.7) 52 (22.6) 
High school 23 (24.2) 42 (31.1) 65 (28.3) 
College or higher 8 (8.4) 18 (13.3) 26 (11.3) 
Marital status    
Married 64 (67.4) 101 (74.8) 165 (71.7) 
Unmarried 9 (9.5) 8 (5.9) 17 (7.4) 
Previously married 22 (23.2) 26 (19.3) 48 (20.9) 
Occupational sector    
Agriculture 9 (9.5) 8 (5.9) 17 (7.4) 
Manufacturing 48 (50.5) 55 (40.7) 103 (44.8) 
Services 38 (40.0) 72 (53.3) 110 (47.8) 
Handedness    
Right dominant 83 (87.4) 124 (91.8) 207 (90.0) 
Left dominant 4 (4.2) 4 (2.9) 8 (3.5) 
Ambidextrous 8 (8.4) 7 (5.2) 15 (6.5) 
Footedness    
Right dominant 83 (87.4) 123 (91.1) 206 (89.6) 
Left dominant 11 (11.6) 10 (7.4) 21 (9.1) 
Ambidextrous 1 (1.0) 2 (1.5) 3 (1.3) 
ALS cases in the family    
Yes 5 (5.3) 2 (1.5) 7 (3.0)  
No 90 (94.7) 133 (98.5) 233 (97.0) 
ALS: Amyotrophic lateral sclerosis. 
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Overall, we recruited 95 (men/women: 51/44) cases and 135 controls (men/women: 71/64). Mean 
age was 65.8 years (standard deviation: 10.9), slightly higher in cases. As regards educational 
attainment, a higher proportion of controls graduated at high school or higher than cases, while 
controls showed a lower proportion of unmarried and previously married participants. Five cases 
and two controls reported at least one relative within the second grade with an ALS diagnosis. Six 
cases revealed a repeat expansion mutation in the C9orf72 gene, and two of them also reported an 
ALS diagnosis in the family. The majority of subjects were right-dominant handed and footed, while 
a few participants reported to be left-dominant or ambidextrous. The distribution of sites of ALS 
onset is reported in Table 2 according to handedness and footedness of cases. We found that right 
dominant handed cases have a slightly higher percentage of bulbar onset compared to non-right 
dominant handed. While we found no substantial difference in right or left-limb onset according to 
handedness, a higher percentage of contralateral onset for non-right dominant footed participants 
was noted. In addition, all cases with bulbar onset were right-dominant footed. When we divided 
sites according to lower or upper limb onset, we found a substantially comparable distribution across 
right and left handed/footed cases. 
Table 2. Distribution of ALS onset sites according to handedness and footedness (divided into right 
and non-right dominant). 















Laterality of onset      
Bilateral onset 16 (19.3) 3 (15.0) 16 (19.3) 3 (25.0) 19 (20.0) 
Right-limb onset 26 (31.3) 4 (33.3) 24 (28.9) 6 (50.0) 30 (31.6) 
Left-limb onset 10 (12.0) 2 (16.7) 11 (13.2) 1 (8.3) 12 (12.6) 
Bulbar 25 (30.1) 2 (16.7) 27 (32.5) 0 (0.0) 27 (28.4) 
Other/trunk 6 (7.2) 1 (8.3) 5 (6.2) 2 (16.7) 7 (7.4) 
Upper/lower onset      
Upper limb onset 22 (26.5) 3 (25.0) 22 (26.5) 3 (25.0) 25 (26.3) 
Right upper limb onset 15 (18.1) 2 (16.7) 15 (18.1) 2 (16.7) 17 (17.9) 
Left upper limb onset 7 (8.4) 1 (8.3) 7 (8.4) 1 (8.3) 8 (8.4) 
Lower limb onset 10 (12.0) 1 (8.3) 10 (12.0) 1 (8.3) 11 (11.6) 
Right lower limb onset 8 (9.6) 0 (0.0) 7 (8.4) 0 (0.0) 7 (8.4) 
Left lower limb onset 2 (2.4) 1 (8.3) 3 (2.4) 1 (8.3) 4 (4.2) 
Bulbar 16 (19.3) 2 (16.7) 18 (21.7) 0 (0.0) 18 (18.9) 
Mixed upper/lower right 3 (3.6) 1 (8.3) 2 (16.7) 2 (16.7) 4 (4.2) 
Mixed upper/lower left 11 (13.2) 3 (25.0) 12 (14.5) 2 (16.7) 14 (14.7) 
Other/trunk 21 (25.3) 2 (16.7) 19 (22.9) 4 (33.3) 23 (24.2) 
Table 3 shows the association between potential risk factors and ALS. In the analysis of dominant 
handedness and footedness, we found a positive association between ALS and both non-right 
dominant handed and footed subjects.  
Table 3. Odds ratio (OR) with 95% confidence interval (CI) of ALS risk according to personal 
characteristics and clinical factors. 
Factors Cases (y/n) 
Controls 
(y/n) OR 
a OR b (95% CI) 
Personal information and habits      
Dominant hand      
Right-handed 83 124 Ref.   
Left-handed 4 4 1.49 1.45 (0.34–6.14) 
Ambidextrous 8 7 1.71 1.73 (0.59–5.02) 
Non-right handed 12/83 11/124 1.63 1.63 (0.67–3.92) 
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Table 3. Cont. 
Dominant foot      
Right 85 123 Ref.   
Left 11 10 1.63 1.62 (0.64–4.06) 
Ambidextrous 2 1 0.74 0.78 (0.07–8.84) 
Non-right  12/83 12/123 1.48 1.47 (0.62–3.50) 
Regular use of skin cream c 25/43 66/68 0.60 0.53 (0.27–1.06) 
Having or ever having had amalgam 
fillings c 42/26 79/55 1.12 1.17 (0.62–2.20) 
Regular use of chewing gum c 16/52 18/116 1.99 2.09 (0.92–4.74) 
Eat fish c 48/20 120/14 0.28 0.27 (0.12–0.60) 
Eat ≥3 fish-based meals per week c 6/62 18/116 0.62 0.58 (0.22–1.58) 
Wine drinking c 43/52 85/50 0.49 0.46 (0.26–0.82) 
Alcohol units intake c,d 10/58 21/113 0.93 0.98 (0.42–2.28) 
Main source of drinking water      
No preference 34 46 Ref. Ref.  
Municipal water 24 55 0.59 0.55 (0.28–1.07) 
Private wells 4 3 1.80 1.44 (0.29–7.03) 
Bottled water 33 31 1.44 1.24 (0.62–2.44) 
Current use of any private well water 12/83 9/126 2.02 1.91 (0.76–4.79) 
Ever use a private well/fountain for 
drinking water 38/57 46/89 1.29 1.38 (0.73–2.27) 
Current use of a private well/fountain 
for irrigation 14/81 30/105 0.60 0.57 (0.28–1.16) 
Ever smoking 49/46 65/70 1.15 1.19 (0.68–2.09) 
Current smoking 11/84 15/112 1.05 1.00 (0.42–2.35) 
Use of the following dietary 
supplements in the former 20 years: 26/69 46/89 0.73 0.70 (0.39–1.25) 
Vitamin supplements 17/78 29/106 0.80 0.80 (0.40–1.59) 
Vitamin and mineral supplements 16/79 27/108 0.81 0.73 (0.36–1.47) 
Aminoacidic supplements 4/91 2/133 2.92 2.81 (0.47–16.87) 
Energy drinks 7/88 11/124 0.90 0.88 (0.31–2.51) 
Selenium-containing supplements 23/72 37/98 0.85 0.88 (0.47–1.65) 
Clinical history      
Any trauma requesting medical 
evaluation 35/60 49/86 1.02 1.14 (0.64–2.01) 
Head trauma 19/76 13/122 2.35 2.61 (1.19–5.72) 
Trunk trauma 9/86 8/127 1.66 1.76 (0.64–4.85) 
Arm trauma 16/79 39/96 0.50 0.52 (0.27–1.02) 
Any fracture 34/61 54/81 0.84 0.85 (0.49–1.48) 
Head fracture 3/92 1/134 4.37 4.07 (0.40–41.30) 
Trunk fracture 6/89 10/125 0.84 0.93 (0.31–2.73) 
Arm fracture 26/69 45/90 0.75 0.75 (0.41–1.35) 
Electric shock trauma 7/88 5/130 2.07 2.09 (0.62–7.06) 
Previous Polio vaccine 41/54 66/69 0.79 0.75 (0.41–1.35) 
Previous spinal anesthesia 24/71 36/99 0.93 0.94 (0.51–1.74) 
Ever been blood donor 24/71 37/98 0.90 0.98 (0.53–1.84) 
Any surgery 76/19 113/22 0.78 0.75 (0.37–1.53) 
with general anesthesia 23/53 35/78 0.97 0.97 (0.51–1.85) 
ALS cases in the family 5/90 2/133 3.69 3.56 (0.65–19.45) 
a Crude model; b Model adjusted by sex, age, and educational attainment; c Section missing for 28 
subjects due to pilot version of the questionnaire. Analysis performed in 202 participants only (68 
cases/134 controls); d Recommended alcohol units (two alcohol units in men, one unit in women) used 
as cutoff points. 
With a view to personal habits, we found an inverse association between risk and regular fish 
consumption (OR = 0.27, 95% CI 0.12–0.60). However, There was no evidence of a dose-response 
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association because an intake equal to or higher than 3 times per week was required to show an OR 
of 0.58 (95% CI 0.22–1.58). Similarly, any wine consumption was inversely associated with ALS (OR 
= 0.46, 95% CI 0.26–0.82), whilst consumption of alcohol units higher than recommended (>2 alcohol 
units/day in men and >1/day unit in women) was not associated with disease risk. Use of private 
wells as a main source (≥70%) of drinking water showed a positive association compared with 
municipal tap water (OR = 1.44, 95% CI 0.29–7.03), along with the use of a private well as a source of 
drinking water (OR = 1.38, 95% CI 0.73–2.27). History of dietary supplements use in the past 20 years 
showed a virtually null association with the disease, although we found a higher ALS risk in the few 
subjects reporting use of amino acid supplements (OR = 2.81, 95% CI 0.47–16.87). Finally, while 
current smoking showed no association with ALS risk, history of ever smoking showed a positive 
though imprecise association (OR = 1.19, 95% CI 0.68–2.09). 
As far as clinical history is concerned, a positive history of any trauma requesting medical 
evaluation showed a very loose association (OR = 1.14, 95% CI 0.64–2.01), but further stratified 
analysis demonstrated a positive association with head trauma (OR = 2.61, 95% CI 1.19–5.72), and 
partially with trunk trauma (OR = 1.76, 95% CI 0.64–4.85). Similarly, only head fracture seems 
positively associated with ALS, however based on its occurrence in 3 cases and 1 control only. We 
found no change in disease risk for a history of polio vaccine, blood donation, any surgery, including 
in those who had undergone general anesthesia. Finally, we found a higher risk for subjects reporting 
a positive history of ALS in the family (OR = 3.56, 95% CI 0.65–19.45). 
We found a limited difference in risk for leisure activities (Table 4), alongside a positive 
association with use of herbicides during gardening, model making, and an inverse association with 
photograph darkroom printing. As for sports, playing any sport showed a slightly inverse association 
(OR = 0.77, 95% CI 0.41–1.42) including those at a competitive level. A slightly increased risk was 
associated with soccer at a competitive level (OR = 1.19, 95% IC 0.35–4.02), skiing (OR = 1.48, 95% CI 
0.42–5.13), and marginally with swimming (OR = 1.61, 95% 0.09–27.33) due the very low number of 
exposed subjects. Sensitivity analysis after exclusion of subjects with a positive family history of ALS 
yielded substantially comparable results (Tables S1–S2). Stratified analysis carried out in men and 
women separately showed substantially comparable results with some exceptions (Tables S3–S6). In 
particular, we found a higher risk for use of amalgam fillings in men but not in women, as well as for 
the use of private wells for drinking water and for use of selenium-containing supplements. 
Conversely, ever smoking posed a higher risk in women, along with the consumption of more alcohol 
units than recommended (Tables S3–S4). In addition, we found higher estimates in men compared to 
women for any trauma, particularly head trauma, and any fracture. In relation to sports, a positive 
association was found with skiing in men, and with swimming in women, which was not evident 
from the overall analysis (Tables S5–S6). Finally, in stratified analyses according to study area, i.e., 
Northern and Southern Italy, we noted a very high risk for ever smoking in the Southern but not in 
the Northern Italian population, as was the case for use of amalgam fillings (Tables S7–S8). Similarly, 
use of private wells for drinking water was clearly associated with ALS risk in the Northern Italian 
population. On the other hand, we found a weaker association in the Southern Italian population, 
which in turn demonstrated a higher risk for use of private wells for irrigation (Tables S7–S8). As 
concerns use of dietary supplements, interestingly, an increased risk emerged in the Catania 
population for the use of vitamin and mineral supplements, and for selenium-containing 
supplements. In addition, data indicated a higher risk for trauma, head trauma, and a history of 
general or spinal anesthesia, as compared to the Northern Italy population (Table S8). With regard to 
leisure activities, we found an increased risk for gardening and painting in the Catania population, 
while we found a positive association with ALS for pesticides and herbicides use for Northern Italy 
(Tables S9–S10). We finally repeated all study analyses by excluding cases carrying the C9orf72 gene 
mutation (Tables S11–S12). No major change in strength and direction of relative risk estimates 
occurred in the analysis restricted to subjects without such gene mutation. 
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Table 4. Odds ratio (OR) with 95% confidence interval (CI) of ALS risk according to leisure activities 






a OR b (95% CI) 
Hunting 4/91 6/129 0.95 1.05 (0.27–4.09) 
Fishing 20/75 37/98 0.71 0.60 (0.29–1.24) 
Using lead 16/79 32/103 0.65 0.57 (0.27–1.22) 
Using lead in fishermen only 16/4 32/5 0.62 0.86 (0.15–4.75) 
Painting 6/89 13/122 0.63 0.70 (0.25–1.98) 
Use of oil paints 2/93 8/127 0.34 0.39 (0.08–1.96) 
Use of oil paints in painters only 2/4 8/5 0.31 0.43 (0.04–4.90) 
Model-making 7/88 8/127 1.26 1.39 (0.47–4.15) 
Gardening 42/53 65/70 0.85 0.95 (0.55–1.64) 
Any use of pesticides? 20/75 28/107 1.02 1.06 (0.55–2.05) 
Using pesticides for gardening? 16/79 21/114 1.10 1.15 (0.56–2.39) 
Using herbicides for gardening? 16/79 13/122 1.90 1.95 (0.88–4.36) 
Using fungicides for gardening? 7/88 12/123 0.82 0.93 (0.35–2.51) 
Photograph darkroom printing? 5/90 24/111 0.26 0.24 (0.09–0.70) 
Play Sports 38/57 63/72 0.76 0.77 (0.41–1.42) 
Competitive sports 10/85 22/113 0.60 0.50 (0.22–1.17) 
Soccer 14/81 21/114 0.94 0.75 (0.33–1.72) 
Competitive soccer 6/89 6/129 1.45 1.19 (0.35–4.02) 
Volleyball 5/90 11/124 0.63 0.59 (0.19–1.87) 
Competitive volleyball 1/94 4/131 0.35 0.28 (0.03–2.64) 
Cycling 5/90 7/128 1.02 1.00 (0.29–3.44) 
Competitive cycling 1/94 5/131 0.35 0.31 (0.03–2.94) 
Swimming 5/90 7/128 1.02 1.12 (0.31–4.06) 
Competitive swimming 1/94 1/134 1.43 1.61 (0.09–27.33) 
Skiing 5/90 7/128 1.02 1.48 (0.42–5.13) 
Competitive skiing 0/95 0/135 - -  
Athletics 7/88 16/119 0.59 0.66 (0.25–1.74) 
Competitive athletics 0/95 6/129 - -  
Tennis 4/94 7/128 0.80 0.96 (0.26–3.53) 
Competitive tennis 1/94 0/135 - -  
a Crude model; b Model adjusted by sex, age, and educational attainment. 
4. Discussion 
Epidemiological investigations have suggested associations between ALS and a large number of 
environmental risk factors. However, evidence for each of them is still inadequate and inconsistent 
[21–23]. In this study, we investigated whether some of these potential environmental risk factors 
may play a role in the onset of sporadic ALS in four Italian populations from different areas of the 
country. 
Interestingly, we observed an inverse association with fish consumption when we compared no 
consumption with regular consumption and used three or more fish-based meals as cutoff point. 
Nonetheless, no evidence of a dose-response relation emerged, and the association was considerably 
weaker in women than in men. A large cohort study carried out in the US investigating the role of 
dietary factors failed to confirm the association with fish intake [24], while another study carried out 
in Italy reported a decreased risk only in the highest quartile compared to the lowest [25]. A pooled 
analysis of five prospective US studies suggested a protective role for foods high in omega-6 and 
omega-3 long-chain polyunsaturated fatty acids [26]. These contrasting results may be due to the 
heterogeneity behind fish consumption, i.e., lake versus sea fish, kind of and relationship with 
possible contaminants [27]. 
We found a positive association between disease risk and use of private wells for drinking water 
but not for cultivation. This was the case despite the low number of exposed subjects and the fact that 
the association seems limited to men, which strongly reduces the reliability of our results. Previous 
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studies have already suggested a positive association with the percentage of the population using 
well water and mortality rates for motor neuron diseases [28,29], possibly linked to fungal or bacterial 
contamination [30,31]. This mainly applies to cyanobacteria due to production of β-N-methylamino-
L-alanine (BMAA), a neurotoxin that may enter the food chain [31–34]. Interestingly, other findings 
linked ALS with living near lakes with the presence of algal bloom [35,36]. However, we did not 
assess water contamination through sample analysis, thus hampering the possible link with a specific 
biological agent. It is noteworthy that a previous cohort study reported an increased risk of ALS 
associated with exposure to inorganic hexavalent selenium through municipal tap water [37,38]. In 
this study, however, we found that use of drinking water from municipal utilities is associated with 
lower ALS risk compared with the use of either municipal or bottled water. While selenium content 
of municipal tap water in Italy is usually negligible, its levels in bottled and particularly well water 
may vary considerably [39,40], and further investigation about the role of this or other elements in 
raising ALS risk through exposure via drinking water is definitely required [41]. Possible differences 
in well water contamination may also explain the stronger association we found for the Northern 
Italy population compared to the Southern one, a difference which warrants further investigation. 
As regards alcohol intake, although our results indicated an inverse association between wine 
or alcohol consumption and ALS, consistent with other reports [25,42,43], null [44] and positive 
associations [26,45] have also been described. In addition, considering the adverse effects of alcohol, 
we carried out an analysis using recommended alcohol units as cutoff points. Overall, we found no 
difference in risk in participants, with a possible higher risk in women, suggesting caution in 
considering wine or alcohol to be either protective from risk factors for ALS. 
The positive association we found between ALS and smoking habits is consistent with previous 
studies [42,45–53]. Despite a few studies reporting no difference or a decreasing risk in association 
with smoking [43,54,55], nevertheless, a detrimental effect of smoking has also been reported as a 
negative prognostic factor [56,57]. This strengths the relevance of quitting in either preventing the 
onset or delaying the progression of the disease. 
As far as dominant handedness and site of onset are concerned, we found no concordance 
between dominant handedness and ipsilateral onset. Conversely, a higher percentage of cases 
signaled an upper-limb onset compared to lower limb onset. Our findings contrast with those from 
a previous study reporting a concordance between handedness and side of onset in upper limb onset 
patients [58]. Conversely, we found similar results in terms of absence of concordance between 
footedness and side of onset [58,59]. Potential reasons for such a difference in site of onset have been 
derived from the greater connectivity in the dominant motor cortex with respect to handedness [60]. 
This difference in excitability of dominant and non-dominant hemispheres [61] may be relevant to 
disease onset, due to the neuronal hyperexcitability occurring in the cortex during early stages of ALS 
[62,63]. A similar explanation was suggested for the higher risk of upper-limb as opposed to lower-
limb onset. 
With regard to dietary supplements, we found contrasting results. Although there were a low 
number of exposed subjects in such categories, only use of amino acid supplements showed a positive 
association with disease risk, while null/inverse relations could be noted for other supplements. It is 
noteworthy that a few investigations reported an inverse association with vitamin E supplements 
[64,65], but no significant associations were found for vitamin C or multivitamins use [65], consistent 
with our study. Interestingly, with reference to the positive association with use of amino acid 
compounds, an experimental study has shown that β-N-methylamino-L-alanine (BMAA), previously 
mentioned with regard to cyanobacteria bloom neurotoxicity [33], and the supplement β-alanine 
have similar and substantial comparable toxicity, despite their low levels [66]. In addition, a side 
effect of β-alanine supplementation is paresthesia (tingling) [67], suggesting caution in its 
administration, at least at high doses, within dietary supplements [68]. 
The hypothesis that trauma increases ALS risk has been suggested by several studies [43,69–74], 
with specific reference to head trauma [42,75–80], and column and trunk trauma [81,82]. However, 
inconsistent results have been reported by other studies [83–86]. One possible explanation for the 
increased ALS risk after traumatic events could be the inclusion of subjects as ALS cases who were 
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affected by chronic traumatic encephalomyelopathy associated with motor neuron disease. This 
might have been confused with ALS, especially in older studies [13,87]. In our study, however, only 
‘definite’ and ‘probable’ ALS cases were recruited, thus ruling out the occurrence of a misdiagnosis. 
Another possible explanation is that the enhanced occurrence of trauma may represent an early, 
subclinical sign of ALS onset, and may therefore be due to reverse causation [88]. However, in the 
analysis excluding head trauma over the previous five years from the date of diagnosis (N = 3 cases 
and 3 controls), we found comparable results (OR = 2.69, 95% CI 1.14–6.36). 
In our study, we found a positive yet imprecise association between previous electric shocks and 
ALS. This confirms previous observations demonstrating an increased risk [84,89–93], but not others 
showing no association [94,95]. Electrical injury may cause a wide range of morphological changes in 
the central nervous system [96], including neuronophagia, neuronal chromatolysis, neuronal loss, 
and microglial activation, which is considered an early event in central nervous system damage [97]. 
Some medical procedures have been investigated in relation to ALS risk [43,82,89,98–100]. Since 
it has been suggested that viral infections may be associated with ALS [13,84,101], we investigated 
whether polio vaccination history could be associated with disease risk. However, we found null to 
inverse association, consistent with a previous study [99]. 
In our study, we found an imprecise inverse association with overall sport playing and ALS risk, 
and limited evidence of a positive association with competitive soccer. Competitive swimming also 
showed a positive association. Nonetheless, this was statistically very imprecise and weak, based as 
it was on two exposed subjects only, suggesting extreme caution in the interpretation of these results. 
Most studies evaluating overall and individual sport playing generally showed an increased risk 
[43,53,75,77,83,102–107], although different results have also been reported [42,54,94,108–110]. 
Remarkably, our results showed an increased risk for skiers, consistent with recent findings about 
Swiss competitive players [111]. In addition, a higher incidence of ALS has been reported in 
professional athletes, especially soccer players. Thus, an attempt has been made to understand the 
role of strenuous sport and physical activity [112–114]. Exercise could alter the extent of exposure or 
could influence the distribution, metabolism or potency of an excitotoxin [115]. It has been suggested 
that a physically active lifestyle and contact sports may be particularly associated with an increased 
probability of trauma [116], especially head trauma for some sports such as soccer or football [117]. 
As for other leisure activities, we find a loose association, in line with previous studies [54,95]. The 
only exception was a marginal increase for use of pesticides during gardening, particularly 
herbicides, which appears to be consistent with previous observations [54,118,119]. 
This study has some limitations that must be acknowledged. First of all, the population-based 
design of the study, particularly with reference to the eligible controls, was associated with a low 
response rate. This reduced the overall sample size and affected the precision of the risk estimates. 
As far as cases are concerned, we acknowledge that a few deceased and seriously ill subjects may 
have not been included. In such cases, we expected that the questionnaire could be filled out by 
caregivers or other relatives. Nevertheless, when we assessed the distribution of individual 
characteristics of study cases and controls, and we compared it with that of the general population 
[120,121], only limited differences emerged. This suggests that there is little evidence of selection bias. 
In particular, the distribution of educational level in controls was comparable to the Italian 
population over 35 years based on the 2011 census data (http://dati-censimentopopolazione.istat.it/ 
Index.aspx). The limited sample size is also due to the low ALS incidence in the study areas, around 
1–2 cases/100,000 inhabitants [7,8,122,123]. 
We also acknowledge that the exposure assessment, solely based on self-report by the 
participants or their proxy respondents, could have been affected by imprecision due to the long 
period of time involved, and even by recall bias. This might have been the case especially when 
seeking long-term or historical information about former exposure to contaminants and other factors 
perceived by the cases as being associated with disease risk. In addition, the reliability and accuracy 
in recalling historical exposures dating back to several years before enrolment in the study may be 
challenged. However, we do not expect major differences between cases and controls in this matter, 
not even for differential recall bias due to the substantially limited awareness of potential risk factors 
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for ALS. Finally, the observational design of the study does not allow us to rule out the possibility 
that some unmeasured confounding may have occurred. 
Some strengths of our investigation should also be outlined. Firstly, it is worth pointing out its 
population-based design: we recruited controls from the general population, by randomly extracting 
them from Local Health Authority registries. This is mandatory for all Italian residents, thus limiting 
the occurrence of selection bias. Secondly, the study area encompassing four Italian provinces 
allowed us to increase the sample size of this case-control study, as compared with previous 
investigations. In addition, it enabled us to assess the associations under investigation in markedly 
different populations with reference to lifestyle and environmental exposures, if not genetic factors 
[124]. Finally, we were able to perform sensitivity analysis by excluding subjects reporting a history 
of ALS in their relatives or carrying the C9orf72 genetic mutation [84], in order to assess the specific 
role of environmental risk factors for sporadic ALS. Such restricted analysis yielded no substantially 
different results. 
5. Conclusions 
The results of the present case-control study suggest a possible association between some non-
genetic risk factors and ALS risk, namely trauma, particularly head trauma or fracture, electric shock, 
some competitive sport activities, use of private wells for drinking water, use of herbicides during 
gardening and consumption of some specific dietary supplements. Caution in interpreting these 
results should be used in light of the study limitations, such as the small sample size and the reduced 
statistical precision of the risk estimates, particularly when a low number of subjects are exposed, the 
potential for exposure misclassification and unmeasured confounding, and the risk of reverse 
causation due to the case-control study design. In addition, the toxicological mechanisms 
underpinning the association between the environmental factors identified in this study and disease 
risk remain to be elucidated. Therefore, further epidemiologic studies on the environmental 
determinants of ALS are clearly needed, and they should encompass a careful validation of historical 
exposures and control of potential confounders. 
Supplementary Materials: Table S1. Odds ratio (OR) with 95% confidence interval (CI) of ALS risk according to 
personal characteristics and clinical factors without subjects with a family history of ALS. Table S2. Odds ratio 
(OR) with 95% confidence interval (CI) of ALS risk according to leisure activities and other lifestyle factors 
without subjects with a family history of ALS. Table S3. Odds ratio (OR) with 95% confidence interval (CI) of 
ALS risk according to personal characteristics and clinical factors in men. Table S4. Odds ratio (OR) with 95% 
confidence interval (CI) of ALS risk according to personal characteristics and clinical factors in women. Table S5. 
Odds ratio (OR) with 95% confidence interval (CI) of ALS risk according to leisure activities and other lifestyle 
factors in men. Table S6. Odds ratio (OR) with 95% confidence interval (CI) of ALS risk according to leisure 
activities and other lifestyle factors in women. Table S7. Odds ratio (OR) with 95% confidence interval (CI) of 
ALS risk according to personal characteristics and clinical factors in the Northern Italy provinces of Modena, 
Novara and Reggio Emilia. Table S8. Odds ratio (OR) with 95% confidence interval (CI) of ALS risk according 
to personal characteristics and clinical factors in the Southern Italy province of Catania. Table S9. Odds ratio (OR) 
with 95% confidence interval (CI) of ALS risk according to leisure activities and other lifestyle factors in the 
Northern Italy provinces of Modena, Novara and Reggio Emilia. Table S10. Odds ratio (OR) with 95% confidence 
interval (CI) of ALS risk according to leisure activities and other lifestyle factors in the Southern Italy province 
of Catania. Table S11. Odds ratio (OR) with 95% confidence interval (CI) of ALS risk according to personal 
characteristics and clinical factors without carriers of C9orf72 mutation. Table S12. Odds ratio (OR) with 95% 
confidence interval (CI) of ALS risk according to leisure activities and other lifestyle factors without carriers of 
C9orf72 mutation. 
Author Contributions: Conceptualization: J.M. and M.V.; Data curation: A.C., C.M., E.A, F.V., G.O.C., L.I., M.C., 
M.Fi., M.T., P.Z. and T.F.; Formal analysis: M.V. and T.F.; Methodology: C.M., J.M., M.Fe., M.Fi., M.V.; Project 
administration: M.Fe., M.T., M.V.; Resources/participants recruitment: E.Z., F.Pa., F.Pi., I.G., J.M., L.M., M.C., 
M.T.; Supervision: M.V.; Visualization: C.M., F.V., T.F.; Writing - original draft: T.F. and M.V.; Writing - review 
& editing: all authors. All authors have read and agreed to the published version of the manuscript. 
Funding: The study was supported by the Local Health Authority of Reggio Emilia. The funder had no role in 
the design, analysis or writing of this article. 
Int. J. Environ. Res. Public Health 2020, 17, 857 11 of 16 
 
Acknowledgments: We thank Stefania Moia from the ‘Centro Regionale Esperto SLA’ of Novara for the support 
in collecting data. 
Conflicts of Interest: The authors declare no conflict of interest. 
References 
1. Gordon, P.H. Amyotrophic lateral sclerosis: An update for 2013 clinical features, pathophysiology, 
management and therapeutic trials. Aging Dis. 2013, 4, 295–310. 
2. Valadi, N. Evaluation and management of amyotrophic lateral sclerosis. Prim. Care 2015, 42, 177–187. 
3. Gale, C.R.; Braidwood, E.A.; Winter, P.D.; Martyn, C.N. Mortality from Parkinson’s disease and other 
causes in men who were prisoners of war in the far east. Lancet 1999, 354, 2116–2118. 
4. Talbott, E.O.; Malek, A.M.; Lacomis, D. The epidemiology of amyotrophic lateral sclerosis. Handb Clin 
Neurol 2016, 138, 225–238. 
5. Marin, B.; Boumediene, F.; Logroscino, G.; Couratier, P.; Babron, M.C.; Leutenegger, A.L.; Copetti, M.; 
Preux, P.M.; Beghi, E. Variation in worldwide incidence of amyotrophic lateral sclerosis: A meta-analysis. 
Int J. Epidemiol 2017, 46, 57–74. 
6. Hardiman, O.; Al-Chalabi, A.; Brayne, C.; Beghi, E.; van den Berg, L.H.; Chiò, A.; Martin, S.; Logroscino, 
G.; Rooney, J. The changing picture of amyotrophic lateral sclerosis: Lessons from European registers. J. 
Neurol. Neurosurg. Psychiatry 2017, 88, 557–563. 
7. Tesauro, M.; Consonni, M.; Filippini, T.; Mazzini, L.; Pisano, F.; Chiò, A.; Esposito, A.; Vinceti, M. Incidence 
of amyotrophic lateral sclerosis in the province of Novara, Italy, and possible role of environmental 
pollution. Amyotroph. Lateral Scler. Front. Degener. 2017, 18, 284–290. 
8. Mandrioli, J.; Biguzzi, S.; Guidi, C.; Venturini, E.; Sette, E.; Terlizzi, E.; Ravasio, A.; Casmiro, M.; Salvi, F.; 
Liguori, R., et al. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna region (Italy): A 
population based study. Amyotroph. Lateral Scler. Front. Degener. 2014, 15, 262–268. 
9. Nicoletti, A.; Vasta, R.; Venti, V.; Mostile, G.; Lo Fermo, S.; Patti, F.; Scillieri, R.; De Cicco, D.; Volanti, P.; 
Marziolo, R., et al. The epidemiology of amyotrophic lateral sclerosis in the Mount Etna region: A possible 
pathogenic role of volcanogenic metals. Eur. J. Neurol 2016, 23, 964–972. 
10. Chiò, A.; Mora, G.; Moglia, C.; Manera, U.; Canosa, A.; Cammarosano, S.; Ilardi, A.; Bertuzzo, D.; Bersano, 
E.; Cugnasco, P., et al. Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta 
register. JAMA Neurol. 2017, 74, 1097–1104. 
11. Boumediene, F.; Vasta, R.; Rascuna, C.; Lo Fermo, S.; Volanti, P.; Marziolo, R.; Patti, F.; Ferrante, M.; Preux, 
P.M.; Marin, B., et al. Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy. 
Eur. J. Neurol 2019, 26, e90-e91. 
12. Zufiria, M.; Gil-Bea, F.J.; Fernandez-Torron, R.; Poza, J.J.; Munoz-Blanco, J.L.; Rojas-Garcia, R.; Riancho, J.; 
de Munain, A.L. ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog. 
Neurobiol. 2016, 142, 104–129. 
13. Ingre, C.; Roos, P.M.; Piehl, F.; Kamel, F.; Fang, F. Risk factors for amyotrophic lateral sclerosis. Clin. 
Epidemiol. 2015, 7, 181–193. 
14. Bozzoni, V.; Pansarasa, O.; Diamanti, L.; Nosari, G.; Cereda, C.; Ceroni, M. Amyotrophic lateral sclerosis 
and environmental factors. Funct. Neurol. 2016, 31, 7–19. 
15. Oskarsson, B.; Horton, D.K.; Mitsumoto, H. Potential environmental factors in amyotrophic lateral sclerosis. 
Neurol. Clin. 2015, 33, 877–888. 
16. Vinceti, M.; Bottecchi, I.; Fan, A.; Finkelstein, Y.; Mandrioli, J. Are environmental exposures to selenium, 
heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis? Rev. Environ. Health 2012, 27, 19–
41. 
17. Vinceti, M.; Violi, F.; Tzatzarakis, M.; Mandrioli, J.; Malagoli, C.; Hatch, E.E.; Fini, N.; Fasano, A.; Rakitskii, 
V.N.; Kalantzi, O.I., et al. Pesticides, polychlorinated biphenyls and polycyclic aromatic hydrocarbons in 
cerebrospinal fluid of amyotrophic lateral sclerosis patients: A case-control study. Environ. Res. 2017, 155, 
261–267. 
18. Vinceti, M.; Filippini, T.; Mandrioli, J.; Violi, F.; Bargellini, A.; Weuve, J.; Fini, N.; Grill, P.; Michalke, B. Lead, 
cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study. 
J. Trace Elem. Med. Biol 2017, 43, 121–125. 
19. Vinceti, M.; Filippini, T.; Wise, L.A. Environmental selenium and human health: An update. Current 
Environ. Health Rep. 2018, 5, 464–485. 
Int. J. Environ. Res. Public Health 2020, 17, 857 12 of 16 
 
20. Brooks, B.R.; Miller, R.G.; Swash, M.; Munsat, T.L.; World Federation of Neurology Research Group on 
Motor Neuron, D. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. 
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000, 1, 293–299. 
21. Vinceti, M. The environment and amyotrophic lateral sclerosis: Converging clues from epidemiologic 
studies worldwide. N. Am. J. Med. Sci. 2012, 4, 356–357. 
22. Belbasis, L.; Bellou, V.; Evangelou, E. Environmental risk factors and amyotrophic lateral sclerosis: An 
umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of 
observational studies. Neuroepidemiology 2016, 46, 96–105. 
23. Martin, S.; Al Khleifat, A.; Al-Chalabi, A. What causes amyotrophic lateral sclerosis? F1000Res 2017, 6, 371. 
24. Morozova, N.; Weisskopf, M.G.; McCullough, M.L.; Munger, K.L.; Calle, E.E.; Thun, M.J.; Ascherio, A. Diet 
and amyotrophic lateral sclerosis. Epidemiology 2008, 19, 324–337. 
25. Pupillo, E.; Bianchi, E.; Chio, A.; Casale, F.; Zecca, C.; Tortelli, R.; Beghi, E. Amyotrophic lateral sclerosis 
and food intake. Amyotroph. Lateral Scler. Front. Degener. 2018, 19, 267–274. 
26. Fitzgerald, K.C.; O’Reilly, E.J.; Falcone, G.J.; McCullough, M.L.; Park, Y.; Kolonel, L.N.; Ascherio, A. Dietary 
omega-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurol. 2014, 
71, 1102–1110. 
27. Lance, E.; Arnich, N.; Maignien, T.; Bire, R. Occurrence of beta-n-methylamino-l-alanine (BMAA) and 
isomers in aquatic environments and aquatic food sources for humans. Toxins 2018, 10, E83. 
28. Schwartz, G.G.; Klug, M.G. Motor neuron disease mortality rates in U.S. States are associated with well 
water use. Amyotroph. Lateral Scler. Front. Degener. 2016, 17, 528–534. 
29. Schwartz, G.G.; Rundquist, B.C.; Simon, I.J.; Swartz, S.E. Geographic distributions of motor neuron disease 
mortality and well water use in U.S. Counties. Amyotroph. Lateral Scler. Front. Degener. 2017, 18, 279–283. 
30. French, P.W.; Ludowyke, R.I.; Guillemin, G.J. Fungal-contaminated grass and well water and sporadic 
amyotrophic lateral sclerosis. Neural Regen. Res. 2019, 14, 1490–1493. 
31. Stipa, G.; Manganelli, M.; Lolli, F. Cyanobacteria biomagnification and amyotrophic lateral sclerosis. Med 
Hypotheses 2013, 81, 356–357. 
32. Buratti, F.M.; Manganelli, M.; Vichi, S.; Stefanelli, M.; Scardala, S.; Testai, E.; Funari, E. Cyanotoxins: 
Producing organisms, occurrence, toxicity, mechanism of action and human health toxicological risk 
evaluation. Arch. Toxicol 2017, 91, 1049–1130. 
33. Bradley, W.G.; Mash, D.C. Beyond Guam: The cyanobacteria/BMAA hypothesis of the cause of ALS and 
other neurodegenerative diseases. Amyotroph Lateral Scler. 2009, 10 Suppl 2, 7-20. 
34. Spencer, P.S.; Ludolph, A.C.; Kisby, G.E. Neurologic diseases associated with use of plant components with 
toxic potential. Environ. Res. 1993, 62, 106–113. 
35. Torbick, N.; Hession, S.; Stommel, E.; Caller, T. Mapping amyotrophic lateral sclerosis lake risk factors 
across northern New England. Int. J. Health Geogr. 2014, 13, 1. 
36. Caller, T.A.; Doolin, J.W.; Haney, J.F.; Murby, A.J.; West, K.G.; Farrar, H.E.; Ball, A.; Harris, B.T.; Stommel, 
E.W. A cluster of amyotrophic lateral sclerosis in New Hampshire: A possible role for toxic cyanobacteria 
blooms. Amyotroph Lateral Scler. 2009, 10, 101-108. 
37. Vinceti, M.; Filippini, T.; Malagoli, C.; Violi, F.; Mandrioli, J.; Consonni, D.; Rothman, K.J.; Wise, L.A. 
Amyotrophic lateral sclerosis incidence following exposure to inorganic selenium in drinking water: A 
long-term follow-up. Environ. Res. 2019, 179, 108742. 
38. Vinceti, M.; Ballotari, P.; Steinmaus, C.; Malagoli, C.; Luberto, F.; Malavolti, M.; Rossi, P.G. Long-term 
mortality patterns in a residential cohort exposed to inorganic selenium in drinking water. Environ. Res. 
2016, 150, 348–356. 
39. Vinceti, M.; Crespi, C.M.; Bonvicini, F.; Malagoli, C.; Ferrante, M.; Marmiroli, S.; Stranges, S. The need for 
a reassessment of the safe upper limit of selenium in drinking water. Sci. Total Environ. 2013, 443, 633–642. 
40. Vinceti, M.; Bonvicini, F.; Rothman, K.J.; Vescovi, L.; Wang, F. The relation between amyotrophic lateral 
sclerosis and inorganic selenium in drinking water: A population-based case-control study. Environ. Health 
2010, 9, 77. 
41. Vinceti, M.; Filippini, T.; Cilloni, S.; Bargellini, A.; Vergoni, A.V.; Tsatsakis, A.; Ferrante, M. Health risk 
assessment of environmental selenium: Emerging evidence and challenges (review). Mol Med. Rep. 2017, 
15, 3323–3335. 
Int. J. Environ. Res. Public Health 2020, 17, 857 13 of 16 
 
42. Lian, L.; Liu, M.; Cui, L.; Guan, Y.; Liu, T.; Cui, B.; Zhang, K.; Tai, H.; Shen, D. Environmental risk factors 
and amyotrophic lateral sclerosis (ALS): A case-control study of als in china. J. Clin. Neurosci. Off. J. 
Neurosurg. Soc. Australas. 2019, 66, 12–18. 
43. Savettieri, G.; Salemi, G.; Arcara, A.; Cassata, M.; Castiglione, M.G.; Fierro, B. A case-control study of 
amyotrophic lateral sclerosis. Neuroepidemiology 1991, 10, 242–245. 
44. D’Ovidio, F.; Rooney, J.P.K.; Visser, A.E.; Manera, U.; Beghi, E.; Logroscino, G.; Vermeulen, R.C.H.; Veldink, 
J.H.; van den Berg, L.H.; Hardiman, O., et al. Association between alcohol exposure and the risk of 
amyotrophic lateral sclerosis in the euro-motor study. J. Neurol Neurosurg Psychiatry 2019, 90, 11–19. 
45. Kamel, F.; Umbach, D.M.; Munsat, T.L.; Shefner, J.M.; Sandler, D.P. Association of cigarette smoking with 
amyotrophic lateral sclerosis. Neuroepidemiology 1999, 18, 194–202. 
46. Armon, C. Smoking may be considered an established risk factor for sporadic ALS. Neurology 2009, 73, 
1693–1698. 
47. Fang, F.; Bellocco, R.; Hernan, M.A.; Ye, W. Smoking, snuff dipping and the risk of amyotrophic lateral 
sclerosis--a prospective cohort study. Neuroepidemiology 2006, 27, 217–221. 
48. Gallo, V.; Bueno-De-Mesquita, H.B.; Vermeulen, R.; Andersen, P.M.; Kyrozis, A.; Linseisen, J.; Kaaks, R.; 
Allen, N.E.; Roddam, A.W.; Boshuizen, H.C., et al. Smoking and risk for amyotrophic lateral sclerosis: 
Analysis of the epic cohort. Ann. Neurol. 2009, 65, 378–385. 
49. Wang, H.; O’Reilly, E.J.; Weisskopf, M.G.; Logroscino, G.; McCullough, M.L.; Thun, M.J.; Schatzkin, A.; 
Kolonel, L.N.; Ascherio, A. Smoking and risk of amyotrophic lateral sclerosis: A pooled analysis of 5 
prospective cohorts. Arch. Neurol. 2011, 68, 207–213. 
50. Weisskopf, M.G.; McCullough, M.L.; Calle, E.E.; Thun, M.J.; Cudkowicz, M.; Ascherio, A. Prospective study 
of cigarette smoking and amyotrophic lateral sclerosis. Am. J. Epidemiol 2004, 160, 26–33. 
51. de Jong, S.W.; Huisman, M.H.; Sutedja, N.A.; van der Kooi, A.J.; de Visser, M.; Schelhaas, H.J.; Fischer, K.; 
Veldink, J.H.; van den Berg, L.H. Smoking, alcohol consumption, and the risk of amyotrophic lateral 
sclerosis: A population-based study. Am. J. Epidemiol 2012, 176, 233–239. 
52. Sutedja, N.A.; Veldink, J.H.; Fischer, K.; Kromhout, H.; Wokke, J.H.; Huisman, M.H.; Heederik, D.J.; Van 
den Berg, L.H. Lifetime occupation, education, smoking, and risk of ALS. Neurology 2007, 69, 1508–1514. 
53. Veldink, J.H.; Kalmijn, S.; Groeneveld, G.J.; Titulaer, M.J.; Wokke, J.H.; van den Berg, L.H. Physical activity 
and the association with sporadic ALS. Neurology 2005, 64, 241–245. 
54. Yu, Y.; Su, F.C.; Callaghan, B.C.; Goutman, S.A.; Batterman, S.A.; Feldman, E.L. Environmental risk factors 
and amyotrophic lateral sclerosis (ALS): A case-control study of ALS in Michigan. PLoS ONE 2014, 9, 
e101186. 
55. Pamphlett, R.; Ward, E.C. Smoking is not a risk factor for sporadic amyotrophic lateral sclerosis in an 
Australian population. Neuroepidemiology 2012, 38, 106–113. 
56. Calvo, A.; Canosa, A.; Bertuzzo, D.; Cugnasco, P.; Solero, L.; Clerico, M.; De Mercanti, S.; Bersano, E.; 
Cammarosano, S.; Ilardi, A., et al. Influence of cigarette smoking on ALS outcome: A population-based 
study. J. Neurol. Neurosurg Psychiatry 2016, 87, 1229–1233. 
57. Wood, H. Motor neuron disease: Smoking adversely affects survival in patients with amyotrophic lateral 
sclerosis. Nature Rev. Neurol. 2016, 12, 615. 
58. Turner, M.R.; Wicks, P.; Brownstein, C.A.; Massagli, M.P.; Toronjo, M.; Talbot, K.; Al-Chalabi, A. 
Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J. Neurol. 
Neurosurg Psychiatry 2011, 82, 853–854. 
59. Devine, M.S.; Woodhouse, H.; McCombe, P.A.; Henderson, R.D. The relationship between limb dominance, 
disease lateralization and spread of weakness in amyotrophic lateral sclerosis (ALS). Amyotroph. Lateral 
Scler. Front. Degener. 2013, 14, 150–151. 
60. Hammond, G. Correlates of human handedness in primary motor cortex: A review and hypothesis. 
Neurosci. Biobehav. Rev. 2002, 26, 285–292. 
61. Baumer, T.; Dammann, E.; Bock, F.; Kloppel, S.; Siebner, H.R.; Munchau, A. Laterality of interhemispheric 
inhibition depends on handedness. Exp. Brain Res. 2007, 180, 195–203. 
62. Rothstein, J.D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol 
2009, 65, S3-9. 
63. Bae, J.S.; Simon, N.G.; Menon, P.; Vucic, S.; Kiernan, M.C. The puzzling case of hyperexcitability in 
amyotrophic lateral sclerosis. J. Clin. Neurol. 2013, 9, 65–74. 
Int. J. Environ. Res. Public Health 2020, 17, 857 14 of 16 
 
64. Wang, H.; O’Reilly, E.J.; Weisskopf, M.G.; Logroscino, G.; McCullough, M.L.; Schatzkin, A.; Kolonel, L.N.; 
Ascherio, A. Vitamin e intake and risk of amyotrophic lateral sclerosis: A pooled analysis of data from 5 
prospective cohort studies. Am. J. Epidemiol 2011, 173, 595–602. 
65. Ascherio, A.; Weisskopf, M.G.; O’Reilly E, J.; Jacobs, E.J.; McCullough, M.L.; Calle, E.E.; Cudkowicz, M.; 
Thun, M.J. Vitamin e intake and risk of amyotrophic lateral sclerosis. Ann. Neurol. 2005, 57, 104–110. 
66. Lee, M.; McGeer, P.L. Weak bmaa toxicity compares with that of the dietary supplement beta-alanine. 
Neurobiol. Aging 2012, 33, 1440–1447. 
67. Trexler, E.T.; Smith-Ryan, A.E.; Stout, J.R.; Hoffman, J.R.; Wilborn, C.D.; Sale, C.; Kreider, R.B.; Jager, R.; 
Earnest, C.P.; Bannock, L., et al. International society of sports nutrition position stand: Beta-alanine. J. Int. 
Soc. Sports Nutr. 2015, 12, 30. 
68. Manuel, M.; Heckman, C.J. Stronger is not always better: Could a bodybuilding dietary supplement lead 
to ALS? Exp. Neurol. 2011, 228, 5–8. 
69. Kurland, L.T.; Radhakrishnan, K.; Smith, G.E.; Armon, C.; Nemetz, P.N. Mechanical trauma as a risk factor 
in classic amyotrophic lateral sclerosis: Lack of epidemiologic evidence. J. Neurol Sci 1992, 113, 133–143. 
70. Peters, T.L.; Weibull, C.E.; Fang, F.; Sandler, D.P.; Lambert, P.C.; Ye, W.; Kamel, F. Association of fractures 
with the incidence of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2017, 18, 419–
425. 
71. Gallagher, J.P.; Sanders, M. Trauma and amyotrophic lateral sclerosis: A report of 78 patients. Acta Neurol. 
Scand. 1987, 75, 145–150. 
72. Wang, M.D.; Little, J.; Gomes, J.; Cashman, N.R.; Krewski, D. Identification of risk factors associated with 
onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. 
Neurotoxicology 2016. 
73. Riggs, J.E. Amyotrophic lateral sclerosis, heterogeneous susceptibility, trauma, and epidemiology. Arch. 
Neurol. 1996, 53, 225–227. 
74. Sienko, D.G.; Davis, J.P.; Taylor, J.A.; Brooks, B.R. Amyotrophic lateral sclerosis. A case-control study 
following detection of a cluster in a small Wisconsin community. Arch. Neurol. 1990, 47, 38–41. 
75. Strickland, D.; Smith, S.A.; Dolliff, G.; Goldman, L.; Roelofs, R.I. Physical activity, trauma, and ALS: A case-
control study. Acta Neurol. Scand. 1996, 94, 45–50. 
76. Williams, D.B.; Annegers, J.F.; Kokmen, E.; O’Brien, P.C.; Kurland, L.T. Brain injury and neurologic 
sequelae: A cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis. Neurology 1991, 41, 
1554–1557. 
77. Halperin Ben Ami, T.; Riccò, M.; Odone, A.; Boccumi, C.; Vinceti, M.; Pietrini, V.; Signorelli, C. Sclérose 
latérale amyotrophique: Analyse des facteurs de risques professionnels. Arch. Mal. Prof. l’Environnemen 
2010, 71, 578. 
78. Chen, H.; Richard, M.; Sandler, D.P.; Umbach, D.M.; Kamel, F. Head injury and amyotrophic lateral 
sclerosis. Am. J. Epidemiol 2007, 166, 810–816. 
79. Tsai, C.P.; Hu, C.; Lee, C.T. Finding diseases associated with amyotrophic lateral sclerosis: A total 
population-based case-control study. Amyotroph. Lateral Scler. Front. Degener. 2019, 20, 82–89. 
80. Seelen, M.; van Doormaal, P.T.; Visser, A.E.; Huisman, M.H.; Roozekrans, M.H.; de Jong, S.W.; van der 
Kooi, A.J.; de Visser, M.; Voermans, N.C.; Veldink, J.H., et al. Prior medical conditions and the risk of 
amyotrophic lateral sclerosis. J. Neurol. 2014, 261, 1949–1956. 
81. Bruske-Hohlfeld, I.; Merritt, J.L.; Onofrio, B.M.; Stonnington, H.H.; Offord, K.P.; Bergstralh, E.J.; Beard, 
C.M.; Melton, L.J., 3rd; Kurland, L.T. Incidence of lumbar disc surgery. A population-based study in 
Olmsted county, Minnesota, 1950–1979. Spine 1990, 15, 31–35. 
82. Chio, A.; Meineri, P.; Tribolo, A.; Schiffer, D. Risk factors in motor neuron disease: A case-control study. 
Neuroepidemiology 1991, 10, 174–184. 
83. Beghi, E.; Logroscino, G.; Chiò, A.; Hardiman, O.; Millul, A.; Mitchell, D.; Swingler, R.; Traynor, B.J. 
Amyotrophic lateral sclerosis, physical exercise, trauma and sports: Results of a population-based pilot 
case-control study. Amyotroph Lateral Scler. 2010, 11, 289–292. 
84. Cruz, D.C.; Nelson, L.M.; McGuire, V.; Longstreth, W.T., Jr. Physical trauma and family history of 
neurodegenerative diseases in amyotrophic lateral sclerosis: A population-based case-control study. 
Neuroepidemiology 1999, 18, 101–110. 
85. Armon, C. Sports and trauma in amyotrophic lateral sclerosis revisited. J. Neurol. Sci. 2007, 262, 45–53. 
Int. J. Environ. Res. Public Health 2020, 17, 857 15 of 16 
 
86. Valenti, M.; Pontieri, F.E.; Conti, F.; Altobelli, E.; Manzoni, T.; Frati, L. Amyotrophic lateral sclerosis and 
sports: A case-control study. Eur. J. Neurol. 2005, 12, 223–225. 
87. Factor-Litvak, P.; Al-Chalabi, A.; Ascherio, A.; Bradley, W.; Chiò, A.; Garruto, R.; Hardiman, O.; Kamel, F.; 
Kasarskis, E.; McKee, A., et al. Current pathways for epidemiological research in amyotrophic lateral 
sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2013, 14, 33–43. 
88. Watanabe, Y.; Watanabe, T. Meta-analytic evaluation of the association between head injury and risk of 
amyotrophic lateral sclerosis. Eur. J. Epidemiol. 2017, 32, 867–879. 
89. Deapen, D.M.; Henderson, B.E. A case-control study of amyotrophic lateral sclerosis. Am. J. Epidemiol 1986, 
123, 790–799. 
90. Fischer, H.; Kheifets, L.; Huss, A.; Peters, T.L.; Vermeulen, R.; Ye, W.; Fang, F.; Wiebert, P.; Vergara, X.P.; 
Feychting, M. Occupational exposure to electric shocks and magnetic fields and amyotrophic lateral 
sclerosis in Sweden. Epidemiology 2015, 26, 824–830. 
91. Huss, A.; Spoerri, A.; Egger, M.; Kromhout, H.; Vermeulen, R.; Swiss National, C. Occupational exposure 
to magnetic fields and electric shocks and risk of ALS: The Swiss National Cohort. Amyotroph. Lateral Scler. 
Front. Degener. 2015, 16, 80–85. 
92. Johansen, C.; Olsen, J.H. Mortality from amyotrophic lateral sclerosis, other chronic disorders, and electric 
shocks among utility workers. Am. J. Epidemiol. 1998, 148, 362–368. 
93. Vergara, X.; Mezei, G.; Kheifets, L. Case-control study of occupational exposure to electric shocks and 
magnetic fields and mortality from amyotrophic lateral sclerosis in the US, 1991–1999. J. Expo. Sci. Environ. 
Epidemiol. 2015, 25, 65–71. 
94. Gunnarsson, L.G.; Bodin, L.; Soderfeldt, B.; Axelson, O. A case-control study of motor neurone disease: Its 
relation to heritability, and occupational exposures, particularly to solvents. Br. J. Ind. Med. 1992, 49, 791–
798. 
95. Chancellor, A.M.; Slattery, J.M.; Fraser, H.; Warlow, C.P. Risk factors for motor neuron disease: A case-
control study based on patients from the Scottish Motor Neuron Disease Register. J. Neurol. Neurosurg 
Psychiatry 1993, 56, 1200–1206. 
96. Abhinav, K.; Al-Chalabi, A.; Hortobagyi, T.; Leigh, P.N. Electrical injury and amyotrophic lateral sclerosis: 
A systematic review of the literature. J. Neurol. Neurosurg Psychiatry 2007, 78, 450–453. 
97. Kreutzberg, G.W. Microglia: A sensor for pathological events in the cns. Trends Neurosci. 1996, 19, 312–318. 
98. Kondo, K.; Tsubaki, T. Case-control studies of motor neuron disease: Association with mechanical injuries. 
Arch. Neurol. 1981, 38, 220–226. 
99. Mitchell, J.D.; Davies, R.B.; al-Hamad, A.; Gatrell, A.C.; Batterby, G. MND risk factors: An epidemiological 
study in the north west of England. J. Neurol. Sci. 1995, 129, 61–64. 
100. Gresham, L.S.; Molgaard, C.A.; Golbeck, A.L.; Smith, R. Amyotrophic lateral sclerosis and occupational 
heavy metal exposure: A case-control study. Neuroepidemiology 1986, 5, 29–38. 
101. Cermelli, C.; Vinceti, M.; Beretti, F.; Pietrini, V.; Nacci, G.; Pietrosemoli, P.; Bartoletti, A.; Guidetti, D.; Sola, 
P.; Bergomi, M., et al. Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for 
herpesviruses and echovirus-7. Eur. J. Epidemiol. 2003, 18, 123–127. 
102. Scarmeas, N.; Shih, T.; Stern, Y.; Ottman, R.; Rowland, L.P. Premorbid weight, body mass, and varsity 
athletics in ALS. Neurology 2002, 59, 773–775. 
103. Harwood, C.A.; Westgate, K.; Gunstone, S.; Brage, S.; Wareham, N.J.; McDermott, C.J.; Shaw, P.J. Long-
term physical activity: An exogenous risk factor for sporadic amyotrophic lateral sclerosis? Amyotroph. 
Lateral Scler. Front. Degener. 2016, 17, 377–384. 
104. Huisman, M.H.; Seelen, M.; de Jong, S.W.; Dorresteijn, K.R.; van Doormaal, P.T.; van der Kooi, A.J.; de 
Visser, M.; Schelhaas, H.J.; van den Berg, L.H.; Veldink, J.H. Lifetime physical activity and the risk of 
amyotrophic lateral sclerosis. J. Neurol Neurosurg Psychiatry 2013, 84, 976–981. 
105. Okamoto, K.; Kihira, T.; Kondo, T.; Kobashi, G.; Washio, M.; Sasaki, S.; Yokoyama, T.; Miyake, Y.; Sakamoto, 
N.; Inaba, Y., et al. Lifestyle factors and risk of amyotrophic lateral sclerosis: A case-control study in Japan. 
Ann. Epidemiol. 2009, 19, 359–364. 
106. Belli, S.; Vanacore, N. Proportionate mortality of italian soccer players: Is amyotrophic lateral sclerosis an 
occupational disease? Eur. J. Epidemiol. 2005, 20, 237–242. 
107. Taioli, E. All causes of mortality in male professional soccer players. Eur. J. Public Health 2007, 17, 600–604. 
Int. J. Environ. Res. Public Health 2020, 17, 857 16 of 16 
 
108. Gallo, V.; Vanacore, N.; Bueno-de-Mesquita, H.B.; Vermeulen, R.; Brayne, C.; Pearce, N.; Wark, P.A.; Ward, 
H.A.; Ferrari, P.; Jenab, M., et al. Physical activity and risk of amyotrophic lateral sclerosis in a prospective 
cohort study. European journal of epidemiology 2016. 
109. Pupillo, E.; Messina, P.; Giussani, G.; Logroscino, G.; Zoccolella, S.; Chiò, A.; Calvo, A.; Corbo, M.; Lunetta, 
C.; Marin, B., et al. Physical activity and amyotrophic lateral sclerosis: A European population-based case-
control study. Ann. Neurol 2014, 75, 708–716. 
110. Longstreth, W.T.; McGuire, V.; Koepsell, T.D.; Wang, Y.; van Belle, G. Risk of amyotrophic lateral sclerosis 
and history of physical activity: A population-based case-control study. Arch. Neurol. 1998, 55, 201–206. 
111. Fang, F.; Hallmarker, U.; James, S.; Ingre, C.; Michaelsson, K.; Ahlbom, A.; Feychting, M. Amyotrophic 
lateral sclerosis among cross-country skiers in Sweden. Eur. J. Epidemiol. 2016, 31, 247–253. 
112. Chiò, A.; Benzi, G.; Dossena, M.; Mutani, R.; Mora, G. Severely increased risk of amyotrophic lateral 
sclerosis among Italian professional football players. Brain  J. Neurol. 2005, 128, 472–476. 
113. Chiò, A.; Calvo, A.; Dossena, M.; Ghiglione, P.; Mutani, R.; Mora, G. ALS in Italian professional soccer 
players: The risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009, 10, 205–209. 
114. Lacorte, E.; Ferrigno, L.; Leoncini, E.; Corbo, M.; Boccia, S.; Vanacore, N. Physical activity, and physical 
activity related to sports, leisure and occupational activity as risk factors for ALS: A systematic review. 
Neurosci. Biobehav. Rev. 2016, 66, 61–79. 
115. Longstreth, W.T.; Nelson, L.M.; Koepsell, T.D.; van Belle, G. Hypotheses to explain the association between 
vigorous physical activity and amyotrophic lateral sclerosis. Med Hypotheses 1991, 34, 144–148. 
116. Blecher, R.; Elliott, M.A.; Yilmaz, E.; Dettori, J.R.; Oskouian, R.J.; Patel, A.; Clarke, A.; Hutton, M.; McGuire, 
R.; Dunn, R., et al. Contact sports as a risk factor for amyotrophic lateral sclerosis: A systematic review. 
Global Spine J. 2019, 9, 104–118. 
117. Feddermann-Demont, N.; Junge, A.; Weber, K.P.; Weller, M.; Dvorak, J.; Tarnutzer, A.A. Prevalence of 
potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients. Brain Behav. 2017, 7, 
e00630. 
118. Morahan, J.M.; Pamphlett, R. Amyotrophic lateral sclerosis and exposure to environmental toxins: An 
Australian case-control study. Neuroepidemiology 2006, 27, 130–135. 
119. Pamphlett, R. Exposure to environmental toxins and the risk of sporadic motor neuron disease: An 
expanded Australian case-control study. Eur. J. Neurol. 2012, 19, 1343–1348. 
120. Ferrante, G.; Minardi, V.; Possenti, V.; Quarchioni, E.; Masocco, M.; Salmaso, S.; Braggion, M.; Campostrini, 
S.; Baldissera, S.; Gruppo Tecnico PASSI. [Smoke: Prevalence is decreasing, but the gap between 
socioeconomic categories remains]. Epidemiol. Prev. 2012, 36, 371. 
121. Gruppo Tecnico PASSI Emilia-Romagna. Sovrappeso e obesità in Emilia-Romagna: Dati del sistema di 
sorveglianza PASSI (anni 2008-2011); Obesity Day 2012 Available online:  
https://www.epicentro.iss.it/passi/pdf2012/EccessoPond_PassiER_08_11.pdf (Accessed 29 January 2020). 
122. Ragonese, P.; Cellura, E.; Aridon, P.; D’Amelio, M.; Spataro, R.; Taiello, A.C.; Maimone, D.; La Bella, V.; 
Savettieri, G. Incidence of amyotrophic lateral sclerosis in Sicily: A population based study. Amyotroph 
Lateral Scler 2012, 13, 284–287. 
123. Bonvicini, F.; Vinceti, M.; Marcello, N.; Rodolfi, R.; Rinaldi, M. The epidemiology of amyotrophic lateral 
sclerosis in Reggio Emilia, Italy. Amyotroph Lateral Scler. 2008, 9, 350–353. 
124. Vinceti, M.; Fiore, M.; Signorelli, C.; Odone, A.; Tesauro, M.; Consonni, M.; Arcolin, E.; Malagoli, C.; 
Mandrioli, J.; Marmiroli, S., et al. Environmental risk factors for amyotrophic lateral sclerosis: 
Methodological issues in epidemiologic studies. Ann. Ig. 2012, 24, 407–415. 
. 
 
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
 
